Stay updated on MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial

Sign up to get notified when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Added Revision: v3.3.2 to the page history and removed Revision: v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-24T16:51:04.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The notice about government funding and operating status was removed from the page.
    Difference
    0.5%
    Check dated 2025-11-17T15:03:29.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The new screenshot shows only a visual/layout refresh of the Record History page without changes to the version data or study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-03T01:31:46.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Core content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.
    Difference
    11%
    Check dated 2025-10-05T10:40:12.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Updates the page version from v3.0.2 to v3.1.0, updating the core metadata/document revision tag.
    Difference
    0.3%
    Check dated 2025-09-28T03:28:57.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Updated the page from v3.0.1 to v3.0.2 and removed the Back to Top element.
    Difference
    0.6%
    Check dated 2025-09-13T17:42:36.000Z thumbnail image

Stay in the know with updates to MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MK-0616-008 Oral PCSK9 Inhibitor Clinical Trial page.